ELIQUENT
ELIQUENT Life Sciences
ELIQUENT Life Sciences offers comprehensive regulatory, quality, and safety solutions for pharmaceutical, biotech, and medical device companies. They specialize in navigating complex regulatory landscapes, including QMSR transitions and CMC solutions.
ELIQUENT Life Sciences is a premier global consulting group providing integrated regulatory affairs, pharmacovigilance, quality, and compliance solutions. They support pharmaceutical, biotechnology, medical device, and combination product companies across various therapeutic modalities and global markets. With a team of former regulators and industry leaders, ELIQUENT offers unparalleled expertise in guiding clients through the entire product lifecycle, from early development to post-approval support. Their services are designed to bring clarity to regulatory complexity, ensuring clients gain and maintain market authorization. ELIQUENT is particularly adept at assisting companies with critical transitions, such as the FDA's shift from QSR to QMSR for medical device manufacturers. They provide tailored solutions, expert commentary, and resources to ensure a smooth and successful adaptation to new regulatory frameworks. Their CMC solutions and remediation services further support companies in achieving and maintaining compliance. Their foundation is built on experts with extensive strategic and technical skills, offering objective and reliable guidance. ELIQUENT's global presence and network of experts enable them to solve complex technical challenges on a global scale, making them a trusted partner for life science innovators.
About
**Who they are**
ELIQUENT Life Sciences is a regulatory, quality, and safety solutions provider for pharmaceutical, biotech, and medical device companies. They specialize in navigating complex regulatory landscapes.
**Expertise & scope**
* Expertise in the FDA’s transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR).
* Support for medical device, in-vitro diagnostic, and combination product industries.
* Focus on harmonizing quality management systems with internationally recognized standards.
* Emphasis on data-driven, risk-based approaches for quality management.
* Assistance with updated processes for quality management and enhanced inspectional responsibilities for regulators.
* Tailored solutions to ensure smooth and successful adaptation to the new QMSR framework.
* Offerings include QMSR Solutions, CMC Solutions, Regulatory Affairs, Quality & Compliance, Pharmacovigilance & Risk Management, Talent Solutions, and Remediation Solutions.
**Reputation / proof points**
* Composed of regulatory leaders, industry experts, and technical specialists.
ELIQUENT Life Sciences is a regulatory, quality, and safety solutions provider for pharmaceutical, biotech, and medical device companies. They specialize in navigating complex regulatory landscapes.
**Expertise & scope**
* Expertise in the FDA’s transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR).
* Support for medical device, in-vitro diagnostic, and combination product industries.
* Focus on harmonizing quality management systems with internationally recognized standards.
* Emphasis on data-driven, risk-based approaches for quality management.
* Assistance with updated processes for quality management and enhanced inspectional responsibilities for regulators.
* Tailored solutions to ensure smooth and successful adaptation to the new QMSR framework.
* Offerings include QMSR Solutions, CMC Solutions, Regulatory Affairs, Quality & Compliance, Pharmacovigilance & Risk Management, Talent Solutions, and Remediation Solutions.
**Reputation / proof points**
* Composed of regulatory leaders, industry experts, and technical specialists.
Additional information
ELIQUENT provides resources to help companies understand and stay ahead of regulatory changes, particularly concerning the QMSR transition. They offer tailored solutions designed to ensure a smooth adaptation to the new framework, emphasizing a data-driven, risk-based approach. Their team comprises regulatory leaders, industry experts, and technical specialists who collaborate to achieve regulatory excellence for their clients. They also offer specific solutions related to CMC (Chemistry, Manufacturing, and Controls) and CAPA (Corrective and Preventive Actions).
Key Highlights
-
Specializes in the FDA's transition from QSR to QMSR for medical device, in-vitro diagnostic, and combination product industries.
Source
“The FDA’s transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR) marks a pivotal shift for the medical device, in-vitro diagnostic, and combination product industry.”
-
Emphasizes a data-driven, risk-based approach for quality management, harmonized with international standards.
Source
“The new streamlined regulation is harmonized with internationally recognized QMS standards and emphasizes a data driven risk-based approach”
-
Offers comprehensive solutions including QMSR, CMC, Regulatory Affairs, Quality & Compliance, and Remediation.
Source
“Solutions Regulatory Affairs CMC Solutions Quality & Compliance CMC Solutions QMSR Solutions Pharmacovigilance & Risk Management Talent Solutions Remediation Solutions”
Certifications & Trust Signals
-
Composed of an assembly of regulatory leaders, industry experts, and technical specialists.
Source
“Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly”
Buyer Snapshot
Best for
- Medical device, in-vitro diagnostic, and combination product companies navigating QMSR transition.
- Organizations seeking to harmonize quality management systems with international standards.
How engagement typically works
- Collaborative approach with regulatory leaders, industry experts, and technical specialists.
- Tailored solutions for specific client needs.
Typical deliverables
- QMSR transition support and consultancy.
- CMC solutions.
- Regulatory affairs guidance.
- Quality and compliance services.
- Remediation solutions.
Good to know
- Best when clients require specialized expertise in FDA regulatory transitions and quality management systems.
HQ:
United States, US
Languages:
English
Timezones:
EST, PST
Claim status:
Listed
Services & Capabilities
FDA QMSR Transition & Inspection Readiness (ISO 13485 Alignment)
Jurisdictions:
US
Countries:
US
Industries:
Medical Devices, IVD
Onboarding time:
7–21 days
Pricing model:
Custom pricing
Service Types:
QMSR/ISO 13485 Gap Assessment, SOP / Documentation Remediation, CAPA & Nonconformance Remediation
Earliest Start:
flexible
Delivery Mode:
Hybrid
Inspection Experience:
Former FDA investigator on team, Supports mock inspections regularly, ISO 13485 lead auditor capability
Additional fda_qmsr_transition_inspection_readiness Details
Service Types
QMSR/ISO 13485 Gap Assessment, SOP/Documentation Remediation, Design Controls/DHF Modernization, CAPA & Nonconformance Remediation, Supplier Controls/Quality Agreements, Internal Audit Program Upgrade, Mock FDA Inspection, Training & Competency Programs, 483 Response & Remediation Support
Earliest Start
flexible
Delivery Mode
Hybrid
Inspection Experience
Supports mock inspections regularly
